Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2023-01-04 2022-11-15
Drug Identification Number 00263818 00263818
Brand name COTAZYM COTAZYM
Common or Proper name PANCRELIPASE CAPSULES PANCRELIPASE CAPSULES
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients PROTEASE AMYLASE LIPASE PROTEASE AMYLASE LIPASE
Strength(s) 35000UNIT 40000UNIT 10000UNIT 35000UNIT 40000UNIT 10000UNIT
Dosage form(s) CAPSULE (IMMEDIATE RELEASE) CAPSULE (IMMEDIATE RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2022-11-21 2022-11-21
Actual start date 2022-11-15 2022-11-15
Estimated end date 2023-01-06 2023-01-06
Actual end date 2023-01-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments